Who is sponsoring NCT05521100?

NCT05521100 is sponsored by Shanghai 10th People's Hospital.

What drugs are being tested in NCT05521100?

Interventions in NCT05521100: Vascular closure device, figure eight stitch.

What condition does NCT05521100 study?

NCT05521100 studies Vascular Access Complications.

Is NCT05521100 still recruiting?

NCT05521100 is currently status unknown. Last updated 27 September 2022.

Last reviewed 2022-09-27 · How we verify

NCT05521100

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Application of Vascular Closure Device in Transvenous Cardiac Intervention

Status unknown NA Last updated 27 September 2022

What this trial tests

NA trial testing Vascular closure device in Vascular Access Complications in 160 participants. Status unknown.

Timeline

30 September 2022

Primary endpoint
1 August 2023

1 December 2023

Quick facts

Lead sponsor	Shanghai 10th People's Hospital
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	160
Start date	30 September 2022
Primary completion	1 August 2023
Estimated completion	1 December 2023
Sites	1 location across China

Drugs / interventions tested

Vascular closure device
figure eight stitch

Conditions studied

Vascular Access Complications — all drugs for Vascular Access Complications →

Sponsor

Shanghai 10th People's Hospital

Who can join

Adults 18 to 85, any sex, with Vascular Access Complications. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Comparison of safety and efficacy between the application of vascular closure device and conventional figure-of-eight suture in transvenous cardiac interventional surgery

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Vascular Access Complications

Currently open trials in the same condition.

NCT06938750 — Novel Medical Device for Pharmacological Therapy · NA · recruiting

Other Shanghai 10th People's Hospital trials

Trials by the same sponsor.

NCT07528040 — An Observational, Multicenter Study to Evaluate the Effectiveness of Guselkumab for the Treatment of Participants With C · not yet recruiting
NCT07370441 — Amino Acid (15) Peritoneal Dialysis Solution for Nutritional Improvement in Peritoneal Dialysis Patients · Phase 4 · not yet recruiting
NCT07328100 — Efficacy and Safety of Coenzyme I for Injection on Vascular Aging. · NA · not yet recruiting
NCT06783296 — Efficacy and Safety of Renal Denervation on Isolated Diastolic Hypertension · NA · not yet recruiting
NCT07204496 — A Clinical Study on the Safety, Tolerance, and Preliminary Efficacy of γδ-T Cell Injection in the Treatment of Advanced · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05521100 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Shanghai 10th People's Hospital
Last refreshed: 27 September 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05521100.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing